Nutrien Ltd vs Koninklijke Philips NV — how do they compare? Nutrien Ltd trades at $70 (market cap $33.31B), while Koninklijke Philips NV trades at $24.51 (market cap $23.52B). The key difference: Nutrien Ltd is the larger of the two by market cap, and Koninklijke Philips NV pays the higher dividend (4.17%). Which is the better fit depends on your goals — on Pluang, investors hold Nutrien Ltd for 59 Days and Koninklijke Philips NV for 84 Days on average.
| NTR | PHG | |
|---|---|---|
Market Cap | $33.31B | $23.52B |
Volume | 1,330,729 | 1,635,069 |
Sector | Basic Materials | Health |
52-Week High | $83.94 | $32.91 |
52-Week Low | $53.64 | $23.81 |
Typical Hold Time | 59 Days | 84 Days |
Enterprise Value | $45.11B | $29.87B |
Dividend Yield | 3.15% | 4.17% |
Signals from Pluang's Aura AI — not financial advice
Nutrien (NTR) trades at $69.97, down 1.73% with bearish technical signals despite recent earnings beats. The stock shows mixed fundamentals with revenue stabilizing around $26-28B and net margins improving to 8.44%. Recent news highlights industry headwinds from potential Belarus potash imports, though strong fertilizer prices and cost discipline support cash flow. Analyst consensus remains moderately bullish with a $76.14 price target, representing 9% upside potential from current levels.
Investment outlook balances cyclical fertilizer demand against structural advantages. Near-term risks include competitive pressure from potential Belarus imports and sulfur cost inflation, but North American gas arbitrage and agricultural cycle recovery provide catalysts. With reasonable valuation (P/E 14.16) and 60% analyst buy ratings, the stock offers value for patient investors despite technical weakness.
PHG trades at $24.09, down 0.25% on the day, with a bearish technical signal despite recent earnings beats. The company shows improving fundamentals with net income turning positive to $895M in 2025 after previous losses, supported by strong operational cash flow of $1.17B. Recent news highlights product innovations including new CT systems and AI healthcare tools, while institutional investors like Bank of America and Arrowstreet Capital have increased positions.
PHG presents a mixed outlook with solid profitability recovery but technical weakness. The stock offers value at reasonable valuations (P/E 18.84, P/S 1.18) and analyst consensus leans Hold (63.64%). Key risks include cybersecurity threats (Reuters, 2026-08-13) and debt levels, while opportunities lie in healthcare technology expansion and Exor's potential increased stake to 22% (Reuters, 2026-08-11).
Trailing returns across standard periods
Created in 2018 as a result of the merger between PotashCorp and Agrium, Nutrien is the world's largest fertilizer producer by capacity. Nutrien produces the three main crop nutrients--nitrogen, potash, and phosphate--although its main focus is potash, where it is the global leader in installed capacity with roughly 20% share. The company is also the largest agricultural retailer in the United States, selling fertilizers, crop chemicals, seeds, and services directly to farm customers through its brick-and-mortar stores and online platforms.
Read more on NTR →Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. About 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (27% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products. In 2021, Philips generated EUR 17.2 billion in sales and had 80,000 employees in over 100 countries.
Read more on PHG →